相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?
V. Kalidasan et al.
FRONTIERS IN MICROBIOLOGY (2020)
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
Ravindra Kumar Gupta et al.
LANCET HIV (2020)
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K. Gupta et al.
NATURE (2019)
CRISPResso2 provides accurate and rapid genome editing sequence analysis
Kendell Clement et al.
NATURE BIOTECHNOLOGY (2019)
Emerging Use of CRISPR Technology - Chasing the Elusive HIV Cure
Carl H. June
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
Lei Xu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+T Cells via CRISPR/Cas9 Confers Resistance to Both X4-and R5-Tropic Human Immunodeficiency Virus Type 1 Infection
Songlin Yu et al.
HUMAN GENE THERAPY (2018)
InducingCCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+Cell Line and Primary CD4+Cells by CRISPR-Cas9 Genome-Editing Technology
Chunxia Qi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus
Bingjie Shi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Refining strategies to translate genome editing to the clinic
Tatjana I. Cornu et al.
NATURE MEDICINE (2017)
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection
Zhepeng Liu et al.
CELL AND BIOSCIENCE (2017)
Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy
Anne-Sophie Gautron et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells
David L. DiGiusto et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Monocyte-derived macrophages exhibit distinct and more restricted HIV-1 integration site repertoire than CD4+ T cells
Yik Lim Kok et al.
SCIENTIFIC REPORTS (2016)
TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells
Anne-Kathrin Dreyer et al.
BIOMATERIALS (2015)
mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5
Ulrike Mock et al.
NUCLEIC ACIDS RESEARCH (2015)
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
Blythe D. Sather et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2015)
Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
Chuka A. Didigu et al.
BLOOD (2014)
The number of CCR5 expressing CD4+T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study
Hinta Meijerink et al.
BMC INFECTIOUS DISEASES (2014)
Microhomology-based choice of Cas9 nuclease target sites
Sangsu Bae et al.
NATURE METHODS (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation
Lambros Kordelas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage
Eli J. Fine et al.
NUCLEIC ACIDS RESEARCH (2014)
TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
Claudio Mussolino et al.
NUCLEIC ACIDS RESEARCH (2014)
Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2
Gero Huetter et al.
AIDS (2011)
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Kristina Allers et al.
BLOOD (2011)
Clinical use of CCR5 inhibitors in HIV and beyond
Bruce L. Gilliam et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Michael S. D. Kormann et al.
NATURE BIOTECHNOLOGY (2011)
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
Claudio Mussolino et al.
NUCLEIC ACIDS RESEARCH (2011)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Decomposition of Gene Expression State Space Trajectories
Jessica C. Mar et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
Targeted genome modifications using integrase-deficient lentiviral vectors
Tatjana I. Cornu et al.
MOLECULAR THERAPY (2007)
Mapping the determinants of the CCRS amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes
EG Cormier et al.
JOURNAL OF VIROLOGY (2001)
分享论文
